Consumer Information Leaflet

STANO®

Stanozolol
10 mg
100 Tablets

Retail Price: 35.00 Interested in Wholesale Pricing?

Available!
POPULARITY
STRENGHT
WEIGHT GAIN
FAT/WATER LOSS
ANTIESTROGEN
SIDE EFFECTS
KEEP GAINS
USAGE
Oral
Consumer Information Leaflet

Why You Should Buy STANO® (Stanozolol) at FULMEN Pharma?

Here at FULMEN Pharma every single day we strive to deliver immaculate German quality anabolic steroids and HGH for our valued customer by ensuring uninterrupted human eye control on all the processes, post-production tests and examinations followed by a strict each product inspection before shipment. We are absolutely confident about your STANO® (Stanozolol) product satisfaction and online shopping experience!

About STANO® (Stanozolol) Product

Stanozolol is a synthetic steroid which elicits a similar action as the naturally occurring steroid testosterone. The use of STANO® (Stanozolol) has been widely documented in the treatment of hereditary diseases such as angioderma which leads to episodes like the occurrence of swellings in the throat, bowel wall, genitals, extremities and on the face. The use of Stanozolol has dramatically reduced the frequency of the attacks. Other than the above-stated purpose, Stanozolol can also be utilized in bodybuilding and muscle gains. It interacts with the muscular system to bring about an increase in the accumulation of muscle mass which comes in handy as a vital tool in the hands of bodybuilders and athletes.

Stanozolol is an androgen and anabolic steroid (AAS) which was derived from dihydrotestosterone (DHT). The non-injectable steroid was developed in 1962 by Winthrop Laboratories (an American Pharmaceutical company). It was approved by the FDA for human use even though its use has been discontinued in the United States. Contrary to what is obtainable with other types of AAS, Stanozolol is not esterified. This is the main reason why it is sold as oral tablets or in aqueous suspensions. It comes with a high level of bioavailability. This is made possible through its ability to pass the liver metabolism when it is ingested. Stanozolol has found use as a commonly utilized performance-enhancing drug and has been used by several athletes and bodybuilders although its use among athletes during competitions has been prohibited.

The use of stanozolol is most common among men since it produces some side effects in women and children. The manifestation of these side effects comes in the form of virilization, fluid retention, deepening of the voice, acne, menstrual abnormalities, and male-pattern baldness. In males, the manifestation of the wrong dosage has been linked with side effects such as edema, prostatic enlargement, and priapism. It may also cause an alteration in libido. This is the reason why dosage must be given much attention among users.

Stanozolol serves as an agonist of the androgen receptor (AR) in a similar manner experienced in other androgens like testosterone and DHT. Since stanozolol is not potentiated in androgenic tissues like the prostate gland, hair follicles, and the skin, it brings about an increase in the ratio of anabolic to androgenic activities when compared with testosterone. It comes with no propensity to produce any form of estrogenic effects and does not possess any progestogenic activity which is worthy of note. It is orally active in humans and thus, the reason why it is made available in tablets and not injections like other AAS. Since the occurrence of the above-mentioned side effects is linked to improper dosing, it is of paramount importance that the dose should be decreased at an interval f 1 to 3 months to a maintenance dose of 2 mg per day.

In summary, each bottle of STANO® (Stanozolol) contains 100 tablets with a concentration of 10 mg of the substance. Dosage is determined by the physician after taking into cognizance some vital health issues in the body.

More
HAPPY CUSTOMERS GALLERY
Received in Sweden
March 6, 2019
Received in Germany
January 20, 2019
Received in Italy
January 5, 2019
Received in United Kingdom
December 18, 2018
Received in Norway
November 13, 2018
Received in United States
October 21, 2018

FIND US ON